{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:11:18Z","timestamp":1758759078800,"version":"3.44.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00256-025-05006-0","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T04:53:35Z","timestamp":1755233615000},"page":"2503-2515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-FDG PET\/CT imaging of inflammatory arthritis"],"prefix":"10.1007","volume":"54","author":[{"given":"Rodolfo","family":"N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Reso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"3","key":"5006_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.dhjo.2019.03.001","volume":"12","author":"KA Theis","year":"2019","unstructured":"Theis KA, Steinweg A, Helmick CG, Courtney-Long E, Bolen JA, Lee R. Which one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. Disabil Health J. 2019;12(3):411\u201321.","journal-title":"Disabil Health J"},{"issue":"40","key":"5006_CR2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.15585\/mmwr.mm7040a2","volume":"70","author":"KA Theis","year":"2021","unstructured":"Theis KA, Murphy LB, Guglielmo D, Boring MA, Okoro CA, Duca LM, et al. Prevalence of arthritis and arthritis-attributable activity limitation - United States, 2016\u20132018. MMWR Morb Mortal Wkly Rep. 2021;70(40):1401\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"5006_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/acr.23425","volume":"70","author":"LB Murphy","year":"2018","unstructured":"Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res (Hoboken). 2018;70(6):869\u201376.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"5006_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.semnuclmed.2022.08.010","volume":"53","author":"F Jamar","year":"2023","unstructured":"Jamar F, van der Laken CJ, Panagiotidis E, Steinz MM, van der Geest KSM, Graham RNJ, et al. Update on imaging of inflammatory arthritis and related disorders. Semin Nucl Med. 2023;53(2):287\u2013300.","journal-title":"Semin Nucl Med"},{"issue":"12","key":"5006_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.medcli.2023.07.014","volume":"161","author":"F D\u00edaz-Gonz\u00e1lez","year":"2023","unstructured":"D\u00edaz-Gonz\u00e1lez F, Hern\u00e1ndez-Hern\u00e1ndez MV. Rheumatoid arthritis. Med Clin (Barc). 2023;161(12):533\u201342.","journal-title":"Med Clin (Barc)"},{"issue":"7 Suppl","key":"5006_CR6","first-page":"S128","volume":"20","author":"A Gibofsky","year":"2014","unstructured":"Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care. 2014;20(7 Suppl):S128-135.","journal-title":"Am J Manag Care"},{"issue":"4","key":"5006_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.berh.2013.09.005","volume":"27","author":"FM McQueen","year":"2013","unstructured":"McQueen FM. Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2013;27(4):499\u2013522.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5006_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.","journal-title":"J Autoimmun"},{"issue":"10055","key":"5006_CR9","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023\u201338.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"5006_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183\u201396.","journal-title":"Immunity"},{"issue":"6","key":"5006_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid arthritis - common origins, divergent mechanisms. N Engl J Med. 2023;388(6):529\u201342.","journal-title":"N Engl J Med"},{"issue":"2","key":"5006_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380\u20136.","journal-title":"Arthritis Rheum"},{"issue":"23","key":"5006_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"3","key":"5006_CR14","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar2689","volume":"11","author":"MA Akhavani","year":"2009","unstructured":"Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther. 2009;11(3):R64.","journal-title":"Arthritis Res Ther"},{"key":"5006_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020905","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022; Jan 14;23(2):905. https:\/\/doi.org\/10.3390\/ijms23020905.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5006_CR16","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med Off Publ, Soc Nucl Med. 1992;33(11):1972\u201380.","journal-title":"J Nucl Med Off Publ, Soc Nucl Med"},{"issue":"5","key":"5006_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00004728-198909000-00014","volume":"13","author":"T Tahara","year":"1989","unstructured":"Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr. 1989;13(5):829\u201331.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"5006_CR18","first-page":"486","volume":"14","author":"M Sasaki","year":"1990","unstructured":"Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Fukumura T, et al. Ringlike uptake of [18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr. 1990;14(3):486\u20137.","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"5006_CR19","first-page":"920","volume":"50","author":"T Matsui","year":"2009","unstructured":"Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, Momose T, et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med Off Publ, Soc Nucl Med. 2009;50(6):920\u20136.","journal-title":"J Nucl Med Off Publ, Soc Nucl Med"},{"issue":"2","key":"5006_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.semnuclmed.2017.11.004","volume":"48","author":"IJE Kouijzer","year":"2018","unstructured":"Kouijzer IJE, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJG. Fever of unknown origin: the value of FDG-PET\/CT. Semin Nucl Med. 2018;48(2):100\u20137.","journal-title":"Semin Nucl Med"},{"key":"5006_CR21","doi-asserted-by":"crossref","unstructured":"Letertre S, Fesler P, Zerkowski L, Picot MC, Ribstein J, Guilpain P, et al. Place of the (18)F-FDG-PET\/CT in the diagnostic workup in patients with classical fever of unknown origin (FUO). J Clin Med. 2021; Augu 26; 10(17):3831.","DOI":"10.3390\/jcm10173831"},{"issue":"8","key":"5006_CR22","first-page":"1048","volume":"62","author":"RL Wahl","year":"2021","unstructured":"Wahl RL, Dilsizian V, Palestro CJ. At last, (18)F-FDG for inflammation and infection! J Nucl Med Off Publ, Soc Nucl Med. 2021;62(8):1048\u20139.","journal-title":"J Nucl Med Off Publ, Soc Nucl Med"},{"issue":"3","key":"5006_CR23","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI117090","volume":"93","author":"A Kubota","year":"1994","unstructured":"Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201\u2013995 in treatment of human endocrine tumors. J Clin Investig. 1994;93(3):1321\u20135.","journal-title":"J Clin Investig"},{"issue":"7","key":"5006_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.rceng.2024.06.005","volume":"224","author":"A Gonz\u00e1lez-Garc\u00eda","year":"2024","unstructured":"Gonz\u00e1lez-Garc\u00eda A, Fabregate M, Serralta G, de Miguel Campo B, Noblejas-Mozo A, Robles-Marhuenda \u00c1. The utility of (18)F-FDG-PET\/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis. A systematic review and meta-analysis. Revista Cl\u00ednica Espa\u00f1ola (English Edition). 2024;224(7):445\u201356.","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"issue":"3","key":"5006_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.semnuclmed.2017.12.005","volume":"48","author":"F Jamar","year":"2018","unstructured":"Jamar F, Versari A, Galli F, Lecouvet F, Signore A. Molecular imaging of inflammatory arthritis and related disorders. Semin Nucl Med. 2018;48(3):277\u201390.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"5006_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1148\/rg.2020190047","volume":"40","author":"M Hotta","year":"2020","unstructured":"Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review. Radiographics. 2020;40(1):223\u201340.","journal-title":"Radiographics"},{"issue":"6","key":"5006_CR27","first-page":"956","volume":"45","author":"C Beckers","year":"2004","unstructured":"Beckers C, Ribbens C, Andr\u00e9 B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med Off Publ Soc Nucl Med. 2004;45(6):956\u201364.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"11","key":"5006_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212660","volume":"77","author":"L Descamps","year":"2018","unstructured":"Descamps L, Olagne L, Merlin C, Cachin F, Soubrier M, Mathieu S. Utility of PET\/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2018;77(11): e81.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5006_CR29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3899\/jrheum.150250","volume":"42","author":"C Buchbender","year":"2015","unstructured":"Buchbender C, Ostendorf B, Ruhlmann V, Heusch P, Miese F, Beiderwellen K, et al. Hybrid 18F-labeled fluoride positron emission tomography\/magnetic resonance (MR) imaging of the sacroiliac joints and the spine in patients with axial spondyloarthritis: a pilot study exploring the link of MR bone pathologies and increased osteoblastic activity. J Rheumatol. 2015;42(9):1631\u20137.","journal-title":"J Rheumatol"},{"key":"5006_CR30","doi-asserted-by":"publisher","unstructured":"Park PSU, Raynor WY, Sun Y, Werner TJ, Rajapakse CS, Alavi A. (18)F-sodium fluoride PET as a diagnostic modality for metabolic, autoimmune, and osteogenic bone disorders: cellular mechanisms and clinical applications. Int J Mol Sci. 2021;22(12):6504.\u00a0https:\/\/doi.org\/10.3390\/ijms22126504.","DOI":"10.3390\/ijms22126504"},{"issue":"9","key":"5006_CR31","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00259-010-1464-7","volume":"37","author":"K Strobel","year":"2010","unstructured":"Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, et al. 18F-fluoride PET\/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging. 2010;37(9):1760\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"5006_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.spinee.2020.03.011","volume":"20","author":"SM Son","year":"2020","unstructured":"Son SM, Kim K, Pak K, Kim SJ, Goh TS, Lee JS. Evaluation of the diagnostic performance of (18)F-NaF positron emission tomography\/computed tomography in patients with suspected ankylosing spondylitis according to the assessment of spondyloarthritis international society criteria. Spine J. 2020;20(9):1471\u20139.","journal-title":"Spine J"},{"issue":"6","key":"5006_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12149-016-1080-0","volume":"30","author":"L Idolazzi","year":"2016","unstructured":"Idolazzi L, Salgarello M, Gatti D, Viapiana O, Vantaggiato E, Fassio A, et al. 18F-fluoride PET\/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity. Ann Nucl Med. 2016;30(6):430\u20134.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"5006_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cpet.2014.07.002","volume":"9","author":"S Hess","year":"2014","unstructured":"Hess S, Hansson SH, Pedersen KT, Basu S, H\u00f8ilund-Carlsen PF. FDG-PET\/CT in infectious and inflammatory diseases. PET Clin. 2014;9(4):497\u2013519, vi\u2212vii.","journal-title":"PET Clin."},{"issue":"3","key":"5006_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102764","volume":"20","author":"JMA van der Krogt","year":"2021","unstructured":"van der Krogt JMA, van Binsbergen WH, van der Laken CJ, Tas SW. Novel positron emission tomography tracers for imaging of rheumatoid arthritis. Autoimmun Rev. 2021;20(3): 102764.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"5006_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64(6):834\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5006_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/art.1780400206","volume":"40","author":"PP Tak","year":"1997","unstructured":"Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997;40(2):217\u201325.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5006_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780390116","volume":"39","author":"D Mulherin","year":"1996","unstructured":"Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39(1):115\u201324.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5006_CR39","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","volume":"43","author":"PP Tak","year":"2000","unstructured":"Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000;43(12):2619\u201333.","journal-title":"Arthritis Rheum"},{"key":"5006_CR40","doi-asserted-by":"publisher","first-page":"6592139","DOI":"10.1155\/2017\/6592139","volume":"2017","author":"B Largeau","year":"2017","unstructured":"Largeau B, Dupont AC, Guilloteau D, Santiago-Ribeiro MJ, Arlicot N. TSPO PET imaging: from microglial activation to peripheral sterile inflammatory diseases? Contrast Media Mol Imaging. 2017;2017:6592139.","journal-title":"Contrast Media Mol Imaging"},{"key":"5006_CR41","doi-asserted-by":"publisher","unstructured":"Uzuegbunam BC, Rummel C, Librizzi D, Culmsee C, Hooshyar Yousefi B. Radiotracers for imaging of inflammatory biomarkers TSPO and COX-2 in the brain and in the periphery. Int J Mol Sci. 2023; 24(24):17419. https:\/\/doi.org\/10.3390\/ijms242417419.","DOI":"10.3390\/ijms242417419"},{"issue":"1","key":"5006_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/art.30655","volume":"64","author":"YY Gent","year":"2012","unstructured":"Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum. 2012;64(1):62\u20136.","journal-title":"Arthritis Rheum"},{"key":"5006_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-015-0770-7","volume":"17","author":"YY Gent","year":"2015","unstructured":"Gent YY, Ter Wee MM, Voskuyl AE, den Uyl D, Ahmadi N, Dowling C, et al. Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study. Arthritis Res Ther. 2015;17:266.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"5006_CR44","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1002\/art.23955","volume":"58","author":"CJ van der Laken","year":"2008","unstructured":"van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, et al. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis Rheum. 2008;58(11):3350\u20135.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"5006_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222844","volume":"14","author":"STG Bruijnen","year":"2019","unstructured":"Bruijnen STG, Verweij NJF, Gent YYJ, Huisman MC, Windhorst AD, Kassiou M, et al. Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers. PLoS One. 2019;14(9): e0222844.","journal-title":"PLoS One"},{"issue":"7","key":"5006_CR46","first-page":"1125","volume":"59","author":"N Narayan","year":"2018","unstructured":"Narayan N, Owen DR, Mandhair H, Smyth E, Carlucci F, Saleem A, et al. Translocator protein as an imaging marker of macrophage and stromal activation in rheumatoid arthritis pannus. J Nucl Med Off Publ Soc Nucl Med. 2018;59(7):1125\u201332.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"10","key":"5006_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140466","volume":"1868","author":"J Holm","year":"2020","unstructured":"Holm J, Hansen SI. Characterization of soluble folate receptors (folate binding proteins) in humans. Biological roles and clinical potentials in infection and malignancy. Biochimica et Biophysica Acta (BBA). 2020;1868(10): 140466.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"8","key":"5006_CR48","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","volume":"56","author":"H Elnakat","year":"2004","unstructured":"Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev. 2004;56(8):1067\u201384.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"5006_CR49","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1158\/1535-7163.MCT-20-0423","volume":"19","author":"AS Dekhne","year":"2020","unstructured":"Dekhne AS, Hou Z, Gangjee A, Matherly LH. Therapeutic targeting of mitochondrial one-carbon metabolism in cancer. Mol Cancer Ther. 2020;19(11):2245\u201355.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"5006_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-019-1123-1","volume":"38","author":"B Frigerio","year":"2019","unstructured":"Frigerio B, Bizzoni C, Jansen G, Leamon CP, Peters GJ, Low PS, et al. Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases. J Exp Clin Cancer Res. 2019;38(1):125.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"5006_CR51","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/ar4191","volume":"15","author":"YY Gent","year":"2013","unstructured":"Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, et al. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Res Ther. 2013;15(2):R37.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5006_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57841-x","volume":"10","author":"NJF Verweij","year":"2020","unstructured":"Verweij NJF, Yaqub M, Bruijnen STG, Pieplenbosch S, Ter Wee MM, Jansen G, et al. First in man study of [(18)F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis. Sci Rep. 2020;10(1): 1047.","journal-title":"Sci Rep"},{"issue":"1","key":"5006_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1325-x","volume":"19","author":"D Chandrupatla","year":"2017","unstructured":"Chandrupatla D, Jansen G, Vos R, Verlaan M, Chen Q, Low PS, et al. In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography. Arthritis Res Ther. 2017;19(1): 114.","journal-title":"Arthritis Res Ther"},{"key":"5006_CR54","doi-asserted-by":"publisher","first-page":"8092781","DOI":"10.1155\/2018\/8092781","volume":"2018","author":"D Chandrupatla","year":"2018","unstructured":"Chandrupatla D, Jansen G, Mantel E, Low PS, Matsuyama T, Musters RP, et al. Imaging and methotrexate response monitoring of systemic inflammation in arthritic rats employing the macrophage PET tracer [(18)F]fluoro-PEG-folate. Contrast Media Mol Imaging. 2018;2018:8092781.","journal-title":"Contrast Media Mol Imaging"},{"issue":"9","key":"5006_CR55","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/ard.2009.119933","volume":"69","author":"P Emery","year":"2010","unstructured":"Emery P, Deodhar A, Rigby WF, Isaacs JD, Combe B, Racewicz AJ, et al. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab\u2019s Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis. 2010;69(9):1629\u201335.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5006_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/annrheumdis-2011-200170","volume":"71","author":"PP Tak","year":"2012","unstructured":"Tak PP, Rigby W, Rubbert-Roth A, Peterfy C, van Vollenhoven RF, Stohl W, et al. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Ann Rheum Dis. 2012;71(3):351\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5006_CR57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-016-1166-z","volume":"18","author":"S Bruijnen","year":"2016","unstructured":"Bruijnen S, Tsang ASM, Raterman H, Ramwadhdoebe T, Vugts D, van Dongen G, et al. B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients. Arthritis Res Ther. 2016;18(1):266.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"5006_CR58","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2174\/1381612043452640","volume":"10","author":"J Juarez","year":"2004","unstructured":"Juarez J, Bendall L, Bradstock K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1\/CXCR4 axis. Curr Pharm Des. 2004;10(11):1245\u201359.","journal-title":"Curr Pharm Des"},{"key":"5006_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.591386","volume":"11","author":"S Santagata","year":"2021","unstructured":"Santagata S, Ieran\u00f2 C, Trotta AM, Capiluongo A, Auletta F, Guardascione G, et al. CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment. Front Oncol. 2021;11: 591386.","journal-title":"Front Oncol"},{"issue":"1","key":"5006_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13578-020-00497-x","volume":"10","author":"HT Nguyen","year":"2020","unstructured":"Nguyen HT, Reyes-Alcaraz A, Yong HJ, Nguyen LP, Park HK, Inoue A, et al. CXCR7: a \u03b2-arrestin-biased receptor that potentiates cell migration and recruits \u03b2-arrestin2 exclusively through G\u03b2\u03b3 subunits and GRK2. Cell Biosci. 2020;10(1):134.","journal-title":"Cell Biosci"},{"key":"5006_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00585","volume":"10","author":"EM Garc\u00eda-Cuesta","year":"2019","unstructured":"Garc\u00eda-Cuesta EM, Santiago CA, Vallejo-D\u00edaz J, Juarranz Y, Rodr\u00edguez-Frade JM, Mellado M. The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases. Front Endocrinol (Lausanne). 2019;10: 585.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"5006_CR62","first-page":"410","volume":"56","author":"K Herrmann","year":"2015","unstructured":"Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor. J Nucl Med Off Publ Soc Nucl Med. 2015;56(3):410\u20136.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"11","key":"5006_CR63","first-page":"1687","volume":"63","author":"AK Buck","year":"2022","unstructured":"Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, et al. Imaging of C-X-C motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using (68)Ga-pentixafor PET. J Nucl Med Off Publ Soc Nucl Med. 2022;63(11):1687\u201392.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"5006_CR64","doi-asserted-by":"crossref","unstructured":"Quinn KA, Ahlman MA, Alessi HD, LaValley MP, Neogi T, Marko J, et al. Association of (18) F-fluorodeoxyglucose-positron emission tomography activity with angiographic progression of disease in large vessel vasculitis. Arthritis Rheumatol. 2023;75(1):98\u2013107.","DOI":"10.1002\/art.42290"},{"key":"5006_CR65","unstructured":"Froehlich M SS, Gernert M, Guggenberger K, Higuchi T, Samnick S, Schmalzing M, Buck A, Bley T, Werner R. C-X-C motif chemokine receptor 4-targeted molecular imaging in giant cell arteritis \u2013 a head-to-head comparison with FDG PET. [abstract]. Arthritis Rheumatol. 2023;75 (suppl 9). https:\/\/acrabstracts.org\/abstract\/c-x-c-motif-chemokine-receptor-4-targeted-molecular-imaging-in-giant-cell-arteritis-a-head-to-head-comparison-with-fdg-pet\/. Accessed 5 Aug 2025."},{"issue":"11","key":"5006_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/RLU.0000000000002258","volume":"43","author":"W Cytawa","year":"2018","unstructured":"Cytawa W, Kircher S, Schirbel A, Shirai T, Fukushima K, Buck AK, et al. Chemokine receptor 4 expression in primary Sj\u00f6gren\u2019s syndrome. Clin Nucl Med. 2018;43(11):835\u20136.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"5006_CR67","first-page":"790","volume":"50","author":"LW Locke","year":"2009","unstructured":"Locke LW, Chordia MD, Zhang Y, Kundu B, Kennedy D, Landseadel J, et al. A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu. J Nucl Med Off Publ Soc Nucl Med. 2009;50(5):790\u20137.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"5","key":"5006_CR68","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/ar3464","volume":"13","author":"T Lowin","year":"2011","unstructured":"Lowin T, Straub RH. Integrins and their ligands in rheumatoid arthritis. Arthritis Res Ther. 2011;13(5):244.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5006_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13550-019-0541-6","volume":"9","author":"J Notni","year":"2019","unstructured":"Notni J, Gassert FT, Steiger K, Sommer P, Weichert W, Rummeny EJ, et al. In vivo imaging of early stages of rheumatoid arthritis by \u03b15\u03b21-integrin-targeted positron emission tomography. EJNMMI Res. 2019;9(1):87.","journal-title":"EJNMMI Res"},{"issue":"6","key":"5006_CR70","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/annrheumdis-2013-204820","volume":"73","author":"Z Zhu","year":"2014","unstructured":"Zhu Z, Yin Y, Zheng K, Li F, Chen X, Zhang F, et al. Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using 68Ga-PRGD2 PET\/CT: a prospective proof-of-concept cohort study. Ann Rheum Dis. 2014;73(6):1269\u201372.","journal-title":"Ann Rheum Dis"},{"issue":"5075","key":"5006_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1126\/science.1529341","volume":"257","author":"M Salmi","year":"1992","unstructured":"Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257(5075):1407\u20139.","journal-title":"Science"},{"issue":"2","key":"5006_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00259-007-0637-5","volume":"35","author":"P Lankinen","year":"2008","unstructured":"Lankinen P, M\u00e4kinen TJ, P\u00f6yh\u00f6nen TA, Virsu P, Salom\u00e4ki S, Hakanen AJ, et al. (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging. 2008;35(2):352\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"26","key":"5006_CR73","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1182\/blood-2009-04-219253","volume":"114","author":"E Kivi","year":"2009","unstructured":"Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, et al. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood. 2009;114(26):5385\u201392.","journal-title":"Blood"},{"issue":"13","key":"5006_CR74","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood-2010-09-311076","volume":"118","author":"K Aalto","year":"2011","unstructured":"Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, et al. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood. 2011;118(13):3725\u201333.","journal-title":"Blood"},{"key":"5006_CR75","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13075-015-0826-8","volume":"17","author":"H Virtanen","year":"2015","unstructured":"Virtanen H, Autio A, Siitonen R, Liljenb\u00e4ck H, Saanijoki T, Lankinen P, et al. 68Ga-DOTA-Siglec-9\u2013a new imaging tool to detect synovitis. Arthritis Res Ther. 2015;17:308.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5006_CR76","first-page":"577","volume":"62","author":"R Viitanen","year":"2021","unstructured":"Viitanen R, Moisio O, Lankinen P, Li XG, Koivum\u00e4ki M, Suilamo S, et al. First-in-humans study of (68)Ga-DOTA-Siglec-9, a PET ligand targeting vascular adhesion protein 1. J Nucl Med Off Publ Soc Nuclear Med. 2021;62(4):577\u201383.","journal-title":"J Nucl Med Off Publ Soc Nuclear Med"},{"issue":"5","key":"5006_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/art.40406","volume":"70","author":"S You","year":"2018","unstructured":"You S, Koh JH, Leng L, Kim WU, Bucala R. The tumor-like phenotype of rheumatoid synovium: molecular profiling and prospects for precision medicine. Arthritis Rheumatol. 2018;70(5):637\u201352.","journal-title":"Arthritis Rheumatol"},{"issue":"7760","key":"5006_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M, et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature. 2019;570(7760):246\u201351.","journal-title":"Nature"},{"issue":"12","key":"5006_CR79","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1007\/s00259-022-05836-3","volume":"49","author":"L Ge","year":"2022","unstructured":"Ge L, Fu Z, Wei Y, Shi D, Geng Y, Fan H, et al. Preclinical evaluation and pilot clinical study of [(18)F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis. Eur J Nucl Med Mol Imaging. 2022;49(12):4025\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"5006_CR80","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222052","volume":"307","author":"Y Luo","year":"2023","unstructured":"Luo Y, Pan Q, Zhou Z, Li M, Wei Y, Jiang X, et al. (68)Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study. Radiology. 2023;307(3): e222052.","journal-title":"Radiology"},{"issue":"12","key":"5006_CR81","first-page":"1914","volume":"52","author":"G Delso","year":"2011","unstructured":"Delso G, F\u00fcrst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner. J Nucl Med Off Publ Soc Nucl Med. 2011;52(12):1914\u201322.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"3","key":"5006_CR82","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cpet.2009.03.003","volume":"3","author":"K Chen","year":"2008","unstructured":"Chen K, Blebea J, Laredo JD, Chen W, Alavi A, Torigian DA. Evaluation of musculoskeletal disorders with PET, PET\/CT, and PET\/MR imaging. PET Clin. 2008;3(3):451\u201365.","journal-title":"PET Clin"},{"issue":"6","key":"5006_CR83","doi-asserted-by":"publisher","first-page":"W245","DOI":"10.2214\/AJR.17.18523","volume":"210","author":"A Gholamrezanezhad","year":"2018","unstructured":"Gholamrezanezhad A, Basques K, Batouli A, Matcuk G, Alavi A, Jadvar H. Clinical nononcologic applications of PET\/CT and PET\/MRI in musculoskeletal, orthopedic, and rheumatologic imaging. AJR Am J Roentgenol. 2018;210(6):W245-w263.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"5006_CR84","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00256-021-03847-z","volume":"50","author":"A Jena","year":"2021","unstructured":"Jena A, Taneja S, Rana P, Goyal N, Vaish A, Botchu R, et al. Emerging role of integrated PET-MRI in osteoarthritis. Skeletal Radiol. 2021;50(12):2349\u201363.","journal-title":"Skeletal Radiol"},{"issue":"3","key":"5006_CR85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1148\/radiology.196.3.7644624","volume":"196","author":"WE Palmer","year":"1995","unstructured":"Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995;196(3):647\u201355.","journal-title":"Radiology"},{"issue":"9","key":"5006_CR86","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s10067-011-1777-3","volume":"30","author":"F Miese","year":"2011","unstructured":"Miese F, Scherer A, Ostendorf B, Heinzel A, Lanzman RS, Kr\u00f6pil P, et al. Hybrid 18F-FDG PET-MRI of the hand in rheumatoid arthritis: initial results. Clin Rheumatol. 2011;30(9):1247\u201350.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"5006_CR87","first-page":"299","volume":"60","author":"RD Badawi","year":"2019","unstructured":"Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med Off Publ Soc Nucl Med. 2019;60(3):299\u2013303.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"1","key":"5006_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.semnuclmed.2024.11.001","volume":"55","author":"S Zoghi","year":"2025","unstructured":"Zoghi S, Mingels C, Badawi RD, Spencer BA, Yarbrough TL, Nardo L, et al. Role of total body PET\/CT in inflammatory disorders. Semin Nucl Med. 2025;55(1):41\u201351.","journal-title":"Semin Nucl Med"},{"issue":"1","key":"5006_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cpet.2020.09.012","volume":"16","author":"AJ Chaudhari","year":"2021","unstructured":"Chaudhari AJ, Raynor WY, Gholamrezanezhad A, Werner TJ, Rajapakse CS, Alavi A. Total-body PET imaging of musculoskeletal disorders. PET Clin. 2021;16(1):99\u2013117.","journal-title":"PET Clin"},{"issue":"10","key":"5006_CR90","first-page":"1579","volume":"63","author":"Y Abdelhafez","year":"2022","unstructured":"Abdelhafez Y, Raychaudhuri SP, Mazza D, Sarkar S, Hunt HL, McBride K, et al. Total-body (18)F-FDG PET\/CT in autoimmune inflammatory arthritis at ultra-low dose: initial observations. J Nucl Med Off Publ Soc Nucl Med. 2022;63(10):1579\u201385.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-025-05006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00256-025-05006-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-025-05006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:04:00Z","timestamp":1758708240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00256-025-05006-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1007\/s00256-025-05006-0","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"type":"print","value":"0364-2348"},{"type":"electronic","value":"1432-2161"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"RN and MR declare they do not have any conflict of interest.DH received publication royalties from Wolters-Kluwer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}